Cargando…

Medication regimen complexity in ambulatory older adults with heart failure

PURPOSE: Heart failure prevalence is increasing in older adults, and polypharmacy is a major problem in this population. We compared medication regimen complexity using the validated patient-level Medication Regimen Complexity Index (pMRCI) tool in “young-old” (60–74 years) versus “old-old” (75–89 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Cobretti, Michael R, Page, Robert L, Linnebur, Sunny A, Deininger, Kimberly M, Ambardekar, Amrut V, Lindenfeld, JoAnn, Aquilante, Christina L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396835/
https://www.ncbi.nlm.nih.gov/pubmed/28442898
http://dx.doi.org/10.2147/CIA.S130832
_version_ 1783230149074878464
author Cobretti, Michael R
Page, Robert L
Linnebur, Sunny A
Deininger, Kimberly M
Ambardekar, Amrut V
Lindenfeld, JoAnn
Aquilante, Christina L
author_facet Cobretti, Michael R
Page, Robert L
Linnebur, Sunny A
Deininger, Kimberly M
Ambardekar, Amrut V
Lindenfeld, JoAnn
Aquilante, Christina L
author_sort Cobretti, Michael R
collection PubMed
description PURPOSE: Heart failure prevalence is increasing in older adults, and polypharmacy is a major problem in this population. We compared medication regimen complexity using the validated patient-level Medication Regimen Complexity Index (pMRCI) tool in “young-old” (60–74 years) versus “old-old” (75–89 years) patients with heart failure. We also compared pMRCI between patients with ischemic cardiomyopathy (ISCM) versus nonischemic cardiomyopathy (NISCM). PATIENTS AND METHODS: Medication lists were retrospectively abstracted from the electronic medical records of ambulatory patients aged 60–89 years with heart failure. Medications were categorized into three types – heart failure prescription medications, other prescription medications, and over-the-counter (OTC) medications – and scored using the pMRCI tool. RESULTS: The study evaluated 145 patients (n=80 young-old, n=65 old-old, n=85 ISCM, n=60 NISCM, mean age 73±7 years, 64% men, 81% Caucasian). Mean total pMRCI scores (32.1±14.4, range 3–84) and total medication counts (13.3±4.8, range 2–30) were high for the entire cohort, of which 72% of patients were taking eleven or more total medications. Total and subtype pMRCI scores and medication counts did not differ significantly between the young-old and old-old groups, with the exception of OTC medication pMRCI score (6.2±4 young-old versus 7.8±5.8 old-old, P=0.04). With regard to heart failure etiology, total pMRCI scores and medication counts were significantly higher in patients with ISCM versus NISCM (pMRCI score 34.5±15.2 versus 28.8±12.7, P=0.009; medication count 14.1±4.9 versus 12.2±4.5, P=0.008), which was largely driven by other prescription medications. CONCLUSION: Medication regimen complexity is high in older adults with heart failure, and differs based on heart failure etiology. Additional work is needed to address polypharmacy and to determine if medication regimen complexity influences adherence and clinical outcomes in this population.
format Online
Article
Text
id pubmed-5396835
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53968352017-04-25 Medication regimen complexity in ambulatory older adults with heart failure Cobretti, Michael R Page, Robert L Linnebur, Sunny A Deininger, Kimberly M Ambardekar, Amrut V Lindenfeld, JoAnn Aquilante, Christina L Clin Interv Aging Original Research PURPOSE: Heart failure prevalence is increasing in older adults, and polypharmacy is a major problem in this population. We compared medication regimen complexity using the validated patient-level Medication Regimen Complexity Index (pMRCI) tool in “young-old” (60–74 years) versus “old-old” (75–89 years) patients with heart failure. We also compared pMRCI between patients with ischemic cardiomyopathy (ISCM) versus nonischemic cardiomyopathy (NISCM). PATIENTS AND METHODS: Medication lists were retrospectively abstracted from the electronic medical records of ambulatory patients aged 60–89 years with heart failure. Medications were categorized into three types – heart failure prescription medications, other prescription medications, and over-the-counter (OTC) medications – and scored using the pMRCI tool. RESULTS: The study evaluated 145 patients (n=80 young-old, n=65 old-old, n=85 ISCM, n=60 NISCM, mean age 73±7 years, 64% men, 81% Caucasian). Mean total pMRCI scores (32.1±14.4, range 3–84) and total medication counts (13.3±4.8, range 2–30) were high for the entire cohort, of which 72% of patients were taking eleven or more total medications. Total and subtype pMRCI scores and medication counts did not differ significantly between the young-old and old-old groups, with the exception of OTC medication pMRCI score (6.2±4 young-old versus 7.8±5.8 old-old, P=0.04). With regard to heart failure etiology, total pMRCI scores and medication counts were significantly higher in patients with ISCM versus NISCM (pMRCI score 34.5±15.2 versus 28.8±12.7, P=0.009; medication count 14.1±4.9 versus 12.2±4.5, P=0.008), which was largely driven by other prescription medications. CONCLUSION: Medication regimen complexity is high in older adults with heart failure, and differs based on heart failure etiology. Additional work is needed to address polypharmacy and to determine if medication regimen complexity influences adherence and clinical outcomes in this population. Dove Medical Press 2017-04-12 /pmc/articles/PMC5396835/ /pubmed/28442898 http://dx.doi.org/10.2147/CIA.S130832 Text en © 2017 Cobretti et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Cobretti, Michael R
Page, Robert L
Linnebur, Sunny A
Deininger, Kimberly M
Ambardekar, Amrut V
Lindenfeld, JoAnn
Aquilante, Christina L
Medication regimen complexity in ambulatory older adults with heart failure
title Medication regimen complexity in ambulatory older adults with heart failure
title_full Medication regimen complexity in ambulatory older adults with heart failure
title_fullStr Medication regimen complexity in ambulatory older adults with heart failure
title_full_unstemmed Medication regimen complexity in ambulatory older adults with heart failure
title_short Medication regimen complexity in ambulatory older adults with heart failure
title_sort medication regimen complexity in ambulatory older adults with heart failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396835/
https://www.ncbi.nlm.nih.gov/pubmed/28442898
http://dx.doi.org/10.2147/CIA.S130832
work_keys_str_mv AT cobrettimichaelr medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT pagerobertl medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT linnebursunnya medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT deiningerkimberlym medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT ambardekaramrutv medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT lindenfeldjoann medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT aquilantechristinal medicationregimencomplexityinambulatoryolderadultswithheartfailure